Tag: factory

Categories
World News

Information exhibits China manufacturing unit exercise progress slowed in August

Chinese stocks fall around 1%; China holds steady on benchmark lending rate

SINGAPORE – Asia Pacific stocks fell mainly in trading on Tuesday as August data showed slower growth in Chinese factory activity.

In mainland China, the Shanghai composite lost 0.75% while the Shenzhen stake lost 1.674%.

China’s factory activity grew more slowly in August compared to the previous month, data released on Tuesday showed. The official purchasing managers’ index for manufacturing was 50.1 in August compared to 50.4 in July.

PMI values ​​above 50 indicate expansion, while those below this value indicate contraction. The PMI readings are sequential and represent a monthly expansion or contraction.

Hong Kong-listed Tencent and Netease stocks fell amid regulatory concerns. They fell 3.18% and 3.46%, respectively, in the city by Tuesday afternoon. It came after new rules released Monday by China’s National Press and Publication Administration showed plans to limit the time people under the age of 18 spend playing video games to just three hours a week.

Hong Kong’s broader Hang Seng index fell 1.43%.

In Japan, the Nikkei 225 was up 0.57% while the Topix index was up 0.32%. South Korea’s Kospi gained 0.61%.

Elsewhere in Australia, the S&P / ASX 200 climbed 0.38%.

MSCI’s broadest index for Asia Pacific stocks outside of Japan fell 0.46%.

CNBC Pro Stock Pick and Investment Trends:

Overnight in the States, the S&P 500 rose 0.43% to 4,528.79 while the tech-heavy Nasdaq Composite rose 0.9% to 15,265.89. The Dow Jones Industrial Average lagged, dropping 55.96 points to 35,399.84 points.

Currencies and oil

The US dollar index, which tracks the greenback versus a basket of its competitors, hit 92.573 after falling above 93.0 last week.

The Japanese yen was trading at 109.86 per dollar, weaker than yesterday against the greenback below 109.8. The Australian dollar was trading at $ 0.7304 and largely held gains after rising below $ 0.72 last week.

Oil prices were lower during Asian trading hours, with international benchmark Brent crude futures falling 0.4% to $ 73.12 a barrel. US crude oil futures declined 0.51% to $ 68.86 a barrel.

– CNBC’s Arjun Kharpal and Lauren Feiner contributed to this report.

Categories
Health

Maker of Speedy Covid Assessments Informed Manufacturing unit to Destroy Stock

Maker of Rapid Covid Tests Told Factory to Destroy Inventory

Aly Morici, Abbott’s director of public affairs, rose to the challenge in the US, saying in an email that “it is difficult to scale to a dime, but we’re doing it again”. She admitted that “there will be some delivery bottlenecks in the coming weeks”.

Abbott invited workers back to the Maine facility this month to meet what a letter described as “unexpected production needs”. However, it is unclear how many employees will be returning. They would forego weeks of non-work remuneration, as provided for in their severance payments, with only a two-week “thank you” salary extension and no guarantee that their job would last.

The company wasn’t in that position in early 2020. In anticipation of fast, reliable testing that did not require specialized equipment, Abbott assembled a team of approximately 100 scientists, supply chain experts, and engineers to develop BinaxNOW in a highly compressed timeframe. The company took risks, imported expensive equipment, and opened two US factories. “Everyone’s been working non-stop,” said Mr. Ford. “That’s what Abbott was built for, in the end.”

The test strip, which is similar to the one on a stretch stick, is less sensitive than the PCR, but provides instant results so a company or school can react immediately.

The FDA granted BinaxNOW emergency approval last August. A day later, the U.S. government announced it would buy 150 million of the tests for $ 760 million – $ 5 per test plus shipping – to be used in facilities such as nursing homes and schools.

Washington’s Friendship Public Charter School received 20,000 government-purchased BinaxNOW tests for free as part of a pilot program supported by the Rockefeller Foundation. Patricia A. Brantley, the school’s general manager, said 70 percent of students’ parents chose to have them wiped once a week. “Testing is still an important part of the strategy to not only reopen schools but keep them open,” said Ms. Brantley.

Northwestern University also introduced BinaxNOW early on and tested the students twice a week. The university was running up to 5,000 rapid tests a day, according to Luke Figora, vice president of operations at the school.

Categories
World News

Foxconn says iPhone manufacturing unit not impacted

Foxconn says iPhone factory not impacted

Vehicles are stranded in floodwater near Zhengzhou Railway Station on July 20, 2021 in Zhengzhou, Henan Province of China.

Zhu Zhe | Visual China Group | Getty Images

GUANGZHOU, China — Taiwan electronics manufacturer Foxconn said Wednesday that its factory in Zhengzhou — known as the world’s largest iPhone assembly plant — has not been impacted by major flooding in the city.

Zhengzhou in China’s central Henan province has been hit with torrential rain. Authorities said it rained more in an hour on Tuesday than it normally would in an average month.

The result has been intense flooding in the city of more than 10 million people. Over 100,000 people have been relocated to safety and 12 people have died, according to state media reports.

Zhengzhou, an important industrial hub, is home to a major factory run by Hon Hai Precision Industry, also known a Foxconn. It is the biggest assembly plant for Apple’s iPhones in the world. Foxconn said its operations had not been affected by the flooding.

Foxconn told CNBC that it had “activated an emergency response plan for flood control measures in that location.”

“We can confirm that there has been no direct impact on our facility in that location to date and we are closely monitoring the situation and will provide any updates as appropriate,” a company spokesperson added.

Apple did not respond to a request for comment.

‘Extremely severe’

Chinese President Xi Jinping called the flooding “extremely severe,” according to his comments published by the official Xinhua news agency.

Unverified videos circulating on Chinese social media such as Twitter-like service Weibo, showed people trapped on a train in Zhengzhou’s subway system submerged in water up to their chests.

Other images show cars floating in flooded streets.

Policemen evacuate traffic in floodwater near Zhengzhou Railway Station on July 20, 2021 in Zhengzhou, Henan Province of China.

Zhu Zhe | Visual China Group | Getty Images

Zhengzhou’s subway network has suspended its operations while hundreds of flights have been cancelled. The army has been called in to help with the rescue efforts.

Various state media reported stories of rescue efforts including 150 kindergarten teachers and students being successfully saved and people being taken off buses stuck in flooded roads.

State-backed newspaper Xinhua, citing the chief forecaster for Henan province’s meteorological station, said the heavy rainfall is expected to last until Wednesday evening.

Categories
Entertainment

For the Chocolate Manufacturing unit Theater, a Scrappy Celebration as It Strikes Properties

For the Chocolate Factory Theater, a Scrappy Celebration as It Moves Homes

As the weekend Pride marches filled town, a different kind of festive procession passed through Long Island City, Queens. On Sunday afternoon, a small but enthusiastic crowd, accompanied by a live marching band and the screeching 7 train, ran – and danced – the mile and a half from 5-49 49th Avenue to 38-29 24th Street.

These addresses are the old and new locations of the Chocolate Factory Theater, an artist-run organization known for giving performers plenty of space, time, and freedom to create. After 17 years in its idiosyncratic rental building on 49th Avenue, the theater is moving to a larger – and probably equally idiosyncratic – permanent home on 24th Street. On Wednesday the founders and directors of the chocolate factory, Sheila Lewandowski and Brian Rogers, handed over the keys to the rooms, which have been rented since 2004, whose white brick walls have seen hundreds of adventurous performances. (Rogers said the next tenant will be a “doggy spa” whose owners are planning a renovation.)

To bid farewell to its long-standing home, the theater hosted two afternoons on Saturday and Sunday with performances along the street in front of the old building, culminating in the procession through the neighborhood on Sunday. The “outdoor quasi-mini-festival”, as it was called, presented more than 20 artists whose work was presented by the chocolate factory. In the performances of Justin Allen, Maria Bauman, Ayano Elson, Keely Garfield, Heather Kravas, Marion Spencer, the music duo Yackez and many others, the mood was solemn and gruff, a fitting homage to the rough room inside.

This intimate space often seemed inseparable from the work that takes place there; its quirks are an endless source of choreographic inspiration. Ask the Chocolate Factory regulars what they’re going to miss about it, and they might mention the nails sticking out of the walls, exposed radiators, or – a popular feature – the elevator shaft in one corner that houses the bright upstairs theater with gloomy basement association (also used for performances).

“I’ve always loved the elevator shaft and watched what people do with this corner, how people crawl in and out,” said Alexandra Rosenberg, executive director of the Center for Performance Research in Brooklyn, who attended both days of the festival. As house manager in the chocolate factory from 2007 to 2012, she also developed a predilection for work that wandered between upstairs and downstairs: “The basement is pretty doomy and gloomy and brings you into a kind of nightmare. It was very effective for many shows. “

On Sunday, the dancers Anna Sperber and Angie Pittman began a duet in this underground room before taking the audience out onto the street – technically the last performance in the old building.

While the rawness of the interior could be challenging, it was part of its appeal as well. “Sometimes a perfectly equipped, spotless room doesn’t really go with a messy, dirty, sweaty, smelly dance,” said Garfield, who took the audience to New York, New York on Saturday in a simple and playful dance routine.

Forced to grapple with architecture, “people did really creative things,” said choreographer Ishmael Houston-Jones, who stopped by the festival on Saturday. He remembered a work by Antonio Ramos that turned the awkward entrance – narrow and sloping – into a tunnel through which the audience stepped out at the end of the show.

“I liked the surface of everything,” said Kravas, who danced a resolute evasive solo to “Repetition” by the Fall on Sunday and disappeared into the building at some point. (To the song she did the whole thing again later.) “You really worked with walls and floors and nails and radiators. In a way, the room was like a different body. “

The room could be enchanting from afar. “I found the chocolate factory on the Internet,” Elson said Saturday after sharing a meditative passage from a recent paper. As a college student, she spent hours delving into the theater’s vast, public Vimeo archive, which contains full-length recordings of performances. Before ever visiting in person, she said it was “a space that I adored and learned from.”

Without permission to really explore, artists might not have found the space so generative. Rogers and Lewandowski, artists themselves (they used to be collaborators, married and then divorced), didn’t set the people there any limits.

“When they say, ‘Come here and play and experiment and move the furniture back and forth and don’t worry about making a mess,’ it really creates an atmosphere that is open to discovery and surprise,” said Garfield. who had several residences in the old building.

When the theater settles in its new home – two adjacent warehouses that were once a tool and mold factory – that ethos is likely to endure, along with the founders’ cultivation of local relationships. Spend some time outside the old room with Lewandowski who lives on the same block and you won’t get very far without a friendly break as she catches up with passing neighbors.

For Bauman – who presented an excerpt from her work “Desire: A Sankofa Dream” on Sunday, a strong pairing of dance and poetry – neighborly thinking is important.

“One thing I appreciate about the chocolate factory,” she said, “is that it not only sees itself as a home for artists, but also as a neighbor of the people, companies and families who are already here.” When she said goodbye was invited, she added: “I had great confidence that it would not be unreasonable for the neighborhood.”

It was a local band, the four members of Liftoff Brass, whose music fueled the move from one Queens theater to another. Lewandowski led the way, stopping to dance on street corners. Along 23rd Street, she pointed to the namesake of the Chocolate Factory, a former pastry shop where she and Rogers once shared a studio with visual artists.

But the mood was more forward-looking than nostalgic; there was a lot to celebrate. Through a rare deal with the city, the chocolate factory acquired its new building debt free, a big deal for a New York nonprofit of its size. Having a permanent facility, Rogers said, “is the only way I know for a small or medium-sized group like ours to survive long term.” The first season in the new build is slated to begin in October, he said.

As the march reached its destination and crossed the threshold of a cool and echoing warehouse, new possibilities came into view: a staircase that led to a small balcony; new corners and protrusions; Skylights let in the late afternoon sun.

“The room in the old chocolate factory is a room in each of us,” Garfield had said the day before, “so we’ll take it to the next room.”

Categories
Business

Inside Astra’s rocket manufacturing facility, as the corporate prepares to go public

Inside Astra's rocket factory, as the company prepares to go public

Astra VP of Manufacturing Bryson Gentile (left) and CEO Chris Kemp remove a protective cover from a missile fairing half.

Michael Sheetz | CNBC

ALAMEDA, Calif. – Astra missile maker wants to simplify the launch business. The soon-to-be-listed company aims to both reduce manufacturing costs and drastically increase the number of starts on a daily rate.

Astra is preparing to go public by the end of June through a merger with SPAC Holicity, which will bring up to $ 500 million in capital to the company. Meanwhile, Astra is expanding its headquarters in San Francisco Bay as the company prepares for its next launch this summer.

A SPAC, or special purpose vehicle, acquires capital from an IPO and uses the proceeds to buy a private company and bring it public.

CNBC toured Astra’s growing facility earlier this month, which was attended by Chairman and CEO Chris Kemp and Vice President of Manufacturing Bryson Gentile.

Benjamin Lyon, Executive Vice President of Engineering, as well as Senior Vice President of Factory Engineering Pablo Gonzalez and Vice President of Communications Kati Dahm also attended.

The company’s management comes from a variety of backgrounds in space and technology: Kemp from NASA and cloud software provider OpenStack, and Gentile from SpaceX. Meanwhile, Lyon came from Apple, Gonzalez from Tesla and Dahm from the electric vehicle manufacturer NIO.

An overview of the location of the Astra headquarters on San Francisco Bay in Alameda, California.

Google Maps

The Astra facility uses the infrastructure left over from the former Air Station Alameda of the US Navy. The company initially started with around 30,000 square meters. It now spans around 250,000 square feet – including all the way to the edge of the bay, where a newly built city ferry terminal connects Alameda with the 10-minute drive from downtown San Francisco.

The main area of ​​the company’s headquarters, approximately 25% of its floor space, provides open space for much of its missile development and assembly.

Astra has also put all of its equipment on wheels, with management emphasizing the flexibility it wants to maintain in expanding its manufacturing capabilities.

The production floor of the Astra headquarters in Alameda, California.

Michael Sheetz | CNBC

The short-term goal is to reach orbit, the next hurdle after the last launch that broke the barrier to space in December. The next launch of Astra is planned for this summer, which will also be the first to generate revenue for the company.

Astra’s rocket is 40 feet high and can launch up to 100 kilograms into orbit. This makes it part of the small rocket category currently led by Rocket Lab.

However, Astra is focused on keeping the price of the rocket as low as possible. It’s priced at just $ 2.5 million per launch versus Rocket Labs Electron’s roughly $ 7 million per launch.

A closer look at half an Astra missile nose cone, also known as a fairing.

Michael Sheetz | CNBC

The company emphasized the cost-cutting methods implemented in its approach, with Astra believing that it is possible to achieve a production rate of one rocket per day within a few years. The company’s employees compare their rocket to building a small Cessna airplane.

An example of Astra demonstrating during the tour how to build fairings – the nose cone of the rocket that protects the satellites during launch.

The company said the first cladding was made of composite carbon fiber, which is typical in the aerospace industry because the material is light and stiff. However, the carbon fiber fairing cost $ 250,000, which required a different solution as the company ultimately wants to bring the total cost of its rocket down to less than $ 500,000.

Astra decided to build its second metal fairing, which cost about $ 130,000. However, the company had to go further.

Vice President Gentile explained how the company is now using aluminum tubing to give the cladding its strength, combining that with a dozen petals, which are thin, curved pieces of metal. That reduces the cost of the fairings to $ 33,000.

Astra plans to get under $ 10,000 per disguise by stamping them instead of riveting them together.

Members of the Astra management team gathered from the right around a rocket in production: Vice President of Production Bryson Gentile, SVP of the factory engineer Dr. Pablo Gonzalez, Vice President of Communication Kati Dahm, Founder and CEO Chris Kemp, EPP of the engineer Benjamin Lyon.

Michael Sheetz | CNBC

Another long-term hurdle for the company will be to work with regulators to get licenses for launches quickly if it is able to hit a daily rate. Astra’s leadership said they are working very closely with the Federal Aviation Administration to streamline the licensing process, noting that they want a dozen or more spaceports around the world.

Astras Mission Control Center for launches.

Michael Sheetz | CNBC

Astra is also optimizing the operational aspect of its launches, reducing the number of people in its mission control to less than 10 and requiring only six people to set up the missile at the physical launch site.

The aim is to reduce the number of people in mission control to just two, effectively a pilot and a co-pilot, by automating most of the processes.

Astra’s outdoor workstation, where pieces of missile ground support equipment are assembled and prepared for launch.

Michael Sheetz | CNBC

The missile system, including the strong back that lifts the vehicle vertically for a launch, is packed in a few shipping containers.

First, Astra rolls a strong back out of the container and into the factory. Then an overhead crane drops the missile directly onto the strongback. Finally, the entire system is rolled into a container and then shipped.

Astra has three strong backs in assembly, more will follow.

The thick doors that led to one of Astra’s rocket engine test facilities, which was previously a US Navy engine test facility.

Michael Sheetz | CNBC

The former marine facility also has two engine test areas with thick reinforced concrete walls.

The night before the CNBC tour, Astra conducted tests on the top tier of a missile. This made the engine bay a cool place thanks to the sub-zero temperatures of a liquid oxygen tank.

In an Astra test bunker where Senior Manager Andrew Pratt shows a pair of fuel tanks connected to a missile that was tested the night before.

Michael Sheetz | CNBC

During a hot fire test, the interior of the chambers reaches 1,200 degrees Fahrenheit when one of Astra’s Dolphin rocket engines is ignited. Astra officials said the company can run up to 10 to 15 first stage tests of a missile in a day, or more than 30 upper stage tests in a day.

Review of the exhaust tunnel of the test bay from Astra.

Michael Sheetz | CNBC

Astra will continue to expand its current presence in Alameda, including a lease for a 500-foot pier and plans for an ocean launch platform that can be loaded with a rocket in the bay.

The view behind Asta’s headquarters in Alameda, California overlooking the San Francisco Bay.

Michael Sheetz | CNBC

Chris Kemp, CEO of Astra, shows part of the space the company plans to use to expand its headquarters.

Michael Sheetz | CNBC

Categories
World News

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Manufacturing facility Combine-Up

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up

Workers at a Baltimore plant that made two coronavirus vaccines accidentally merged the ingredients a few weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay approving the plant’s production lines.

The facility is operated by Emergent BioSolutions, a manufacturing partner of Johnson & Johnson and AstraZeneca, the Anglo-Swedish company whose vaccine is not yet approved for use in the United States. Federal officials attributed the error to human error.

The mix-up has delayed future shipments of Johnson & Johnson cans in the U.S. while the Food and Drug Administration investigates what happened. Johnson & Johnson has strengthened its control over the work of Emergent BioSolutions to avoid additional quality defects.

The mistake is a major embarrassment for both Johnson & Johnson, whose single-dose vaccine is credited with accelerating the national vaccination program, and Emergent, its subcontractor, who has received heavy criticism for its strong lobbying for federal contracts, particularly for the emergency Government Health Stock.

The bug does not affect any Johnson & Johnson cans currently shipped and used nationwide, including shipments that states are anticipating next week. All of these cans were made in the Netherlands, where the operations were fully approved by federal regulators.

More shipments of the Johnson & Johnson vaccine – expected to be 24 million doses next month – should come from the huge Baltimore facility. These supplies are now in question while quality control issues are being resolved according to those familiar with the matter.

Federal officials are still expecting enough doses from Johnson & Johnson and the other two approved coronavirus vaccine manufacturers to meet President Biden’s commitment to provide enough vaccines to immunize every adult by the end of May.

Pfizer is shipping its doses ahead of schedule, and Moderna is about to approve the supply of vaccine bottles of up to 15 doses instead of 10, further strengthening the country’s inventory.

The problems arose at a new facility the federal government hired last year to manufacture vaccines from Johnson & Johnson and AstraZeneca. The two vaccines use the same technology, which uses a harmless version of a virus – known as a vector – that is transferred into cells to make a protein, which then stimulates the immune system to produce antibodies. However, the Johnson and Johnson and AstraZeneca vectors are biologically different and not interchangeable.

At the end of February, one or more employees somehow mixed up the two during the production process and raised questions about training and supervision.

Vaccine manufacturing is a notoriously capricious science, and errors are often expected to occur and ruin batches. However, Emergent’s mistake went undetected for days until Johnson & Johnson quality controls discovered it, according to people familiar with the situation. By then, up to 15 million cans were contaminated, people said.

None of the cans ever left the plant and the lot has been quarantined.

Johnson & Johnson reported the mishap to federal regulators, who opened an investigation that delayed approval of the plant’s production lines. The company has increased the number of its own employees overseeing Emergent’s work and has introduced a number of new controls to protect against future errors.

Johnson & Johnson was already grappling with a manufacturing delay that caused the company to fail to meet its obligations to the federal government, but it appeared to be on track to catching up. 20 million doses had been administered by the end of March, and promises were made to deliver around 75 million additional doses by the end of May.

White House officials backed up their predictions in a phone call with governors on Tuesday. They forecast certain shipments from Pfizer and Moderna, but warned that Johnson & Johnson shipments would fluctuate.

In a statement late Wednesday, the company said it expected the steps it is now taking with Emergent would allow it to drop 24 million doses by the end of April, or whatever the federal government expects. However, this depends on Johnson & Johnson’s compliance with the Food and Drug Administration regulations.

Categories
Politics

Manufacturing facility Combine-Up Ruins As much as 15 Million Vaccine Doses From Johnson & Johnson

Factory Mix-Up Ruins Up to 15 Million Vaccine Doses From Johnson & Johnson

WASHINGTON – Workers at a Baltimore plant that made two coronavirus vaccines accidentally merged the ingredients a few weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay approving the plant’s production lines .

The facility is operated by Emergent BioSolutions, a manufacturing partner of Johnson & Johnson and AstraZeneca, the Anglo-Swedish company whose vaccine is not yet approved for use in the United States. Federal officials attributed the error to human error.

The mix-up has delayed future shipments of Johnson & Johnson cans in the U.S. while the Food and Drug Administration investigates what happened. Johnson & Johnson has strengthened its control over the work of Emergent BioSolutions to avoid additional quality defects.

The mistake is a major embarrassment for both Johnson & Johnson, whose single-dose vaccine is credited with accelerating the national vaccination program, and Emergent, its subcontractor, who has received heavy criticism for its strong lobbying for federal contracts, particularly for the emergency Government Health Stock.

The bug does not affect any Johnson & Johnson cans currently shipped and used nationwide, including shipments that states are anticipating next week. All of these cans were made in the Netherlands, where the operations were fully approved by federal regulators.

More shipments of the Johnson & Johnson vaccine – expected to be 24 million doses next month – should come from the huge Baltimore facility. These supplies are now in question while quality control issues are being resolved according to those familiar with the matter.

Federal officials are still expecting enough doses from Johnson & Johnson and the other two approved coronavirus vaccine manufacturers to meet President Biden’s commitment to provide enough vaccines to immunize every adult by the end of May.

Pfizer is shipping its doses ahead of schedule, and Moderna is about to approve the supply of vaccine bottles of up to 15 doses instead of 10, further strengthening the country’s inventory.

The problems arose at a new facility the federal government hired last year to manufacture vaccines from Johnson & Johnson and AstraZeneca. The two vaccines use the same technology, which uses a harmless version of a virus – known as a vector – that is transferred into cells to make a protein, which then stimulates the immune system to produce antibodies. However, the Johnson and Johnson and AstraZeneca vectors are biologically different and not interchangeable.

At the end of February, one or more employees somehow mixed up the two during the production process and raised questions about training and supervision. Over the past year, Emergent hired and trained hundreds of new employees to make millions of doses of both vaccines that should be ready by the time clinical trials showed that the vaccines were actually working.

Updated

March 31, 2021, 9:32 p.m. ET

Vaccine manufacturing is a notoriously capricious science, and errors are often expected to occur and ruin batches. However, Emergent’s mistake went undetected for days until Johnson & Johnson quality controls discovered it, according to people familiar with the situation. By then, up to 15 million cans were contaminated, people said.

None of the cans ever left the plant and the lot has been quarantined. There is no evidence that production of the AstraZeneca vaccine, which has not yet been approved by the Food and Drug Administration for emergency use, was affected.

Johnson & Johnson reported the mishap to federal regulators, who opened an investigation that delayed approval of the plant’s production lines. The company has increased the number of its own employees overseeing Emergent’s work and has introduced a number of new controls to protect against future errors.

Johnson & Johnson was already grappling with a manufacturing delay that caused the company to fail to meet its obligations to the federal government, but it appeared to be on track to catching up. 20 million doses had been administered by the end of March, and promises were made to dispense approximately another 75 million doses by the end of May.

White House officials backed up their predictions in a phone call with governors on Tuesday. They forecast certain shipments from Pfizer and Moderna, but warned that Johnson & Johnson shipments would fluctuate.

In a statement late Wednesday, the company said it expected the steps it is now taking with Emergent would allow it to drop 24 million doses by the end of April, or whatever the federal government expects. However, this depends on Johnson & Johnson’s compliance with the Food and Drug Administration regulations.

The agency last week cleared a bottling facility that Johnson & Johnson in Indiana is using to release more cans made in the Netherlands. However, this facility cannot ship cans made at the Emergent facility until the Food and Drug Administration approves it.

According to the Centers for Disease Control and Prevention, nearly seven million doses of the vaccine have been given to date, about half of which have been given.

Categories
Business

British EV start-up Arrival North Carolina manufacturing unit to construct a UPS fleet

British EV start-up Arrival North Carolina factory to build a UPS fleet

A UK electric vehicle company has roots in the US and plans to roll out its new production concept globally as the demand for new mobility systems increases.

Arrival, which develops electric vans and buses, announced last week that it is building a second microfactory in Charlotte, North Carolina. The company plans to assemble vehicles for a fleet order from United Parcel Service there from the second half of 2022.

President Avinash Rugoobur told CNBC’s Jim Cramer on Monday that its vertically integrated micro-factories require less space and capital investment than traditional manufacturing facilities.

“We’re working with the city of Charlotte to create a whole transportation ecosystem together,” he said in a Mad Money interview. “If you look at the global scale that needs to be switched to electricity, we expect microfactories all over the world.”

Arrival is investing more than $ 41 million in the Charlotte plant, where the US headquarters are located.

The company plans to go public as part of a blank check merger with Ciig Merger and expects to hire more than 250 employees at the site. This is in addition to the 650 jobs that will be brought into the region as part of the corporate offices announced in December.

According to Arrival, it is a mission to accelerate the transition to zero-emission commercial vehicles. The company claims a competitive advantage by designing its own batteries and other components in-house and writing its own software, Rugoobur said.

“The interesting thing about the microfactory is that you can use existing warehouses and turn them into production facilities,” said Rugoobur.

UPS ordered 10,000 Generation 2 electric vehicles from Arrival almost a year ago to electrify the fleet of delivery vehicles. At the same time, the delivery company took part in Arrival.

The electric vehicles are expected to hit the streets in the next four years.